2021 Federal Pre-Budget Consultation

The industry calls on the federal government to delay implementation of PMPRB regulatory changes until the COVID-19 pandemic has abated. IMC urges the federal government to work with our industry to build a more vibrant life sciences sector – one that enhances patients’ access to innovative medicines and tackles the sector’s critical issues.


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.